The Journal of Immunology, Vol 143, Issue 2 565-570, Copyright © 1989 by American Association of Immunologists

ARTICLES

The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors

GC Stone, U Sjobring, L Bjorck, J Sjoquist, CV Barber and FA Nardella
Department of Medicine, University of Washington, Seattle 98195.

The isolated 35 kDa fragment of protein G obtained by papain digestion of group G streptococci was found to bind solid phase intact IgG, Fc (2C gamma 2 + 2C gamma 3 domains), F(ab')2 and F(acb)2 (F(ab')2 + 2C gamma 2 domains) fragments but not pFc' (2C gamma 3 domains) fragments. The level of binding to rabbit F(acb)2 and rabbit F(ab')2 fragments was similar. Protein G binding to solid phase Fc fragments was inhibited by IgG, Fc, staphylococcal protein A and its monovalent fragment D, but was enhanced by F(ab')2 fragments. Chemical modification of tyrosine but not histidine residues of IgG abrogated its ability to inhibit the binding of protein G to solid phase Fc fragments. Protein G was found to strongly inhibit the binding of a monoclonal and a polyclonal human rheumatoid factor to IgG. These findings indicate that protein G binds with separate sites to the Fc and F(ab')2 fragments of IgG, that the interaction with the Fc fragment occurs at the C gamma 2-C gamma 3 domain interface region and that tyrosine but not histidine residues in this area are likely involved. The relationship of the Fc fragment- binding site specificity of protein G to that of other microbial IgG binding proteins and human rheumatoid factors is discussed.

This article has been cited by other articles:

				D. P. Nitsche-Schmitz, H. M. Johansson, I. Sastalla, S. Reissmann, I.-M. Frick, and G. S. Chhatwal Group G Streptococcal IgG Binding Molecules FOG and Protein G Have Different Impacts on Opsonization by C1q J. Biol. Chem., June 15, 2007; 282(24): 17530 - 17536. [Abstract] [Full Text] [PDF]

				M. Oda, H. Kozono, H. Morii, and T. Azuma Evidence of allosteric conformational changes in the antibody constant region upon antigen binding Int. Immunol., March 1, 2003; 15(3): 417 - 426. [Abstract] [Full Text] [PDF]

				W.-G. Hu, A. Z. Alvi, D. Chau, J. E. Coles, R. E. Fulton, M. R. Suresh, and L. P. Nagata Development and Characterization of a Novel Fusion Protein Composed of a Human IgG1 Heavy Chain Constant Region and a Single-Chain Fragment Variable Antibody against Venezuelan Equine Encephalitis Virus J. Biochem., January 1, 2003; 133(1): 59 - 66. [Abstract] [Full Text] [PDF]

				A. Antonsson and P. J. H. Johansson Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus J. Gen. Virol., May 1, 2001; 82(5): 1137 - 1145. [Abstract] [Full Text]

				T. L. Chapman, I. You, I. M. Joseph, P. J. Bjorkman, S. L. Morrison, and M. Raghavan Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G J. Biol. Chem., March 12, 1999; 274(11): 6911 - 6919. [Abstract] [Full Text] [PDF]

				A. Berge, B.-M. Kihlberg, A. G. Sjoholm, and L. Bjorck Streptococcal Protein H Forms Soluble Complement-activating Complexes with IgG, but Inhibits Complement Activation by IgG-coated Targets J. Biol. Chem., August 15, 1997; 272(33): 20774 - 20781. [Abstract] [Full Text] [PDF]